Effects of polycystic ovary syndrome on liver, heart, muscle, and pancreatic-related diseases - Takeaways - MDSpire

Effects of polycystic ovary syndrome on liver, heart, muscle, and pancreatic-related diseases

  • By

  • Bingrui Li

  • Yuan Li

  • Xianglin Li

  • Zicheng Yu

  • Jin Yu

  • Yang Shao

  • Tonglu Li

  • Shuai Sun

  • Ling Zhou

  • Ruipin Yao

  • Wen Cheng

  • Jing Zhu

  • Jindong Miao

  • You Li

  • Yang Wu

  • Yin Shi

  • Jing Zhou

  • Chaoqin Yu

  • Changquan Ling

  • April 10, 2026

  • 0 min

Share

  • 1

    PCOS affects 11–13% of women and is a systemic metabolic disorder impacting the liver, heart, muscle, and pancreas.

  • 2

    Obese women with PCOS have a 51.61% prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD).

  • 3

    PCOS increases cardiovascular disease risk by 2–4 times and is linked to higher incidences of type 2 diabetes.

  • 4

    The condition is characterized by insulin resistance, hyperandrogenism, inflammation, and oxidative stress, leading to multi-organ dysfunction.

  • 5

    Integrated, multidisciplinary management is essential for addressing the systemic nature of PCOS and its complications.

Original Source(s)

Effects of polycystic ovary syndrome on liver, heart, muscle, and pancreatic-related diseases

  • by Bingrui Li, Yuan Li, Xianglin Li, Zicheng Yu, Jin Yu, Yang Shao, Tonglu Li, Shuai Sun, Ling Zhou, Ruipin Yao, Wen Cheng, Jing Zhu, Jindong Miao, You Li, Yang Wu, Yin Shi, Jing Zhou, Chaoqin Yu, Changquan Ling

  • April 10, 2026

Related Content

Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies

Editorial: Advancing reproductive outcomes: integrating molecular, metabolic, and endocrine insights into oocyte maturation

Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications